Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Elba Marin"'
Autor:
Cristina Aguado, Cristina Teixido, Ruth Román, Roxana Reyes, Ana Giménez‐Capitán, Elba Marin, Carlos Cabrera, Nuria Viñolas, Sergi Castillo, Silvia Muñoz, Ainara Arcocha, Laura López‐Vilaró, Ivana Sullivan, Erika Aldeguer, Sonia Rodríguez, Irene Moya, Santiago Viteri, Andrés Felipe Cardona, Ramon Palmero, Cristina Sainz, Miguel Mesa‐Guzmán, Maria D. Lozano, Andrés Aguilar‐Hernández, Alejandro Martínez‐Bueno, María González‐Cao, Elena Gonzalvo, William P. J. Leenders, Rafael Rosell, Luis M. Montuenga, Aleix Prat, Miguel A. Molina‐Vila, Noemi Reguart
Publikováno v:
Molecular Oncology, Vol 15, Iss 2, Pp 350-363 (2021)
MET inhibitors have shown activity in non‐small‐cell lung cancer patients (NSCLC) with MET amplification and exon 14 skipping (METΔex14). However, patient stratification is imperfect, and thus, response rates have varied widely. Here, we studied
Externí odkaz:
https://doaj.org/article/5db041644f0248ee90bd178c373b1867
Autor:
Elba Marin, Roxana Reyes, Ainara Arcocha, Nuria Viñolas, Laura Mezquita, Elena Gonzalvo, Karmele Saez de Gordoa, Pedro Jares, Noemi Reguart, Cristina Teixido
Publikováno v:
Diagnostics, Vol 10, Iss 11, p 902 (2020)
Targeted therapies are a new paradigm in lung cancer management. Next-generation sequencing (NGS) techniques have allowed for simultaneous testing of several genes in a rapid and efficient manner; however, there are other molecular diagnostic tools s
Externí odkaz:
https://doaj.org/article/60d95f83c184455a9de9adf93c4e32e4
Autor:
Roxana Reyes, Mireia García, Cristina Teixido, Francisco M. Pérez, Roberto Martin-Deleon, Pedro Jares, Naiara Vega, Daniel Martinez, Ramón Mª Marrades, Carlos Agustí, Elba Marin, Ivan Vollmer, Noemi Reguart, Ainhoa Fontana, Nuria Viñolas, Marcelo Sánchez, Carmen M. Lucena
Publikováno v:
Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2084, p 2084 (2021)
Volume 13
Issue 9
Cancers, Vol 13, Iss 2084, p 2084 (2021)
Clinical guidelines promote the identification of several targetable biomarkers to drive treatment decisions in advanced non-small cell lung cancer (NSCLC), but half of all patients do not have a viable biopsy. Specimens from endobronchial-ultrasound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd1c669670bdd57b26275bf15781cfd5
Autor:
Karmele Saez de Gordoa, Elena Gonzalvo, Roxana Reyes, Laura Mezquita, Elba Marin, Cristina Teixidó, Ainara Arcocha, Pedro Jares, Nuria Viñolas, Noemi Reguart
Publikováno v:
Diagnostics
Volume 10
Issue 11
Diagnostics, Vol 10, Iss 902, p 902 (2020)
Volume 10
Issue 11
Diagnostics, Vol 10, Iss 902, p 902 (2020)
Targeted therapies are a new paradigm in lung cancer management. Next-generation sequencing (NGS) techniques have allowed for simultaneous testing of several genes in a rapid and efficient manner
however, there are other molecular diagnostic too
however, there are other molecular diagnostic too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5097f1d9e307363d265c02033b5c2c
Autor:
Elba Marin, Laura López-Vilaró, Santiago Viteri, Sonia Rodríguez, Ana Giménez-Capitán, Ivana Sullivan, Sergi Castillo, Miguel Mesa-Guzman, Noemí Reguart, Rafael Rosell, Ruth Román, Elena Gonzalvo, Silvia Muñoz, Nuria Viñolas, Aleix Prat, Luis M. Montuenga, Cristina Aguado, Maria Gonzalez-Cao, Cristina Teixido, Irene Moya, María Dolores Lozano, Carlos Cabrera, Andrés Felipe Cardona, Ramon Palmero, Roxana Reyes, Miguel Angel Molina-Vila, Erika Aldeguer, Alejandro Martinez-Bueno, Cristina Sainz, Ainara Arcocha, William P.J. Leenders, A. Aguilar-Hernández
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5015f96f9f62f89d44507e87d3eb2b42
https://doi.org/10.1002/1878-0261.12861/v2/response1
https://doi.org/10.1002/1878-0261.12861/v2/response1
Autor:
Sergi Castillo, Nuria Viñolas, Miguel Angel Molina-Vila, MªCarmen Rodríguez-Mues, Pedro Jares, Elba Marin, Roxana Reyes, Mireia García, Carlos R. Cabrera, Noemi Reguart, Marcelo Sánchez, Ainara Arcocha, Silvia Muñoz, I. Sullivan, Antonio Martínez, Aleix Prat, Elena Carmona-Rocha, Ivan Vollmer, Adela Rodriguez, Silvia Alos, Cristina Teixidó
Publikováno v:
Cancers
Volume 12
Issue 5
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cancers, Vol 12, Iss 1124, p 1124 (2020)
Volume 12
Issue 5
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cancers, Vol 12, Iss 1124, p 1124 (2020)
Personalized medicine is nowadays a paradigm in lung cancer management, offering important benefits to patients. This study aimed to test the feasibility and utility of embedding two multiplexed genomic platforms as the routine workup of advanced non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68cf68a072b7b481f710ce57e86a8e10
https://pubmed.ncbi.nlm.nih.gov/32365867
https://pubmed.ncbi.nlm.nih.gov/32365867
Autor:
Silvia Muñoz, William P.J. Leenders, A. Aguilar-Hernández, Luis M. Montuenga, Roxana Reyes, Maria Gonzalez-Cao, R. Roman, Elena Gonzalvo, Cristina Sainz, Cristina Teixidó, Andrés F. Cardona, Maria D. Lozano, Elba Marin, Ainara Arcocha, Carlos R. Cabrera, Miguel Mesa-Guzman, Aleix Prat, Miguel Angel Molina-Vila, I. Sullivan, Cristina Aguado, Alejandro Martinez-Bueno, Erika Aldeguer, Irene Moya, Ramon Palmero, Noemi Reguart, Rafael Rosell, Laura López-Vilaró, Ana Giménez-Capitán, Santiago Viteri, Sonia Rodríguez, Sergi Castillo, Nuria Viñolas
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Molecular Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Fundacion Sancho el Sabio Fundazioa (FSS)
Molecular Oncology, Vol 15, Iss 2, Pp 350-363 (2021)
Molecular Oncology, 15, 350-363
Scientia
Molecular Oncology, 15, 2, pp. 350-363
Universitat Autònoma de Barcelona
Molecular Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Fundacion Sancho el Sabio Fundazioa (FSS)
Molecular Oncology, Vol 15, Iss 2, Pp 350-363 (2021)
Molecular Oncology, 15, 350-363
Scientia
Molecular Oncology, 15, 2, pp. 350-363
We studied MET alterations in 474 advanced non‐small‐cell lung cancer (NSCLC) patients by nCounter, an RNA‐based technique. We identified 3% with METΔex14 mRNA and 3.5% with very‐high MET mRNA expression, a surrogate of MET amplification. ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c00b42c81cc41a7f2eb1ec563f3b10
https://ddd.uab.cat/record/238801
https://ddd.uab.cat/record/238801
Autor:
Cristina Aguado, Irene Moya, Andrés Aguilar, Ana Gimenez Capitan, Rafael Rosell, Noemi Reguart, Nuria Viñolas, Santiago Viteri, Ruth Román, Sonia Rodríguez, Elba Marin, Cristina Teixidó, Roxana Reyes, Miguel Angel Molina-Vila
Publikováno v:
Cancer Research. 81:469-469
Background: Fusion involving anaplastic lymphoma kinase (ALK), RET proto-oncogene (RET) or ROSproto-oncogene 1, receptor tyrosine kinase (ROS1), neurotrophic receptor tyrosine kinase 1 (NTRK1)and neuregulin 1 (NRG1) are present in lung cancer (LC) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ade646f1c745daf333fb89854fbc7107
https://doi.org/10.1158/1538-7445.am2021-469
https://doi.org/10.1158/1538-7445.am2021-469
Autor:
Cristina Teixidó, Noemi Reguart, Pedro Jares, Clara Mayo-de-las-Casas, Miguel Angel Molina-Vila, Ivan Vollmer, Mónica Garzón, Elba Marin, Carlos Cabrera, Roxana Reyes
Publikováno v:
Clinical lung cancer. 20(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc547efadf0e1326e4013cf5a2bea4cd
https://pubmed.ncbi.nlm.nih.gov/30926357
https://pubmed.ncbi.nlm.nih.gov/30926357
Autor:
Laia Paré, Pedro Jares, Andrés F. Cardona, Daniel Martinez, Miguel Angel Molina-Vila, Elena Gonzalvo, Ivana Sullivan, Cristina Aguado, Sandra Lopez-Prades, Elba Marin, R. Roman, Carlos R. Cabrera, Laura Lopez, Cristina Teixidó, Ana Giménez-Capitán, Aleix Prat, Noemi Reguart
Publikováno v:
Cancer Research. 79:131-131
Background: PD-L1 immunohistochemistry (IHC) staining is currently accepted as the gold-standard biomarker for immune therapy in advanced non-small cell lung cancer (NSCLC). However, the use of various antibodies and cut-offs as well as certain degre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c58d8483f8d7c1cc926f485db69b7e3
https://doi.org/10.1158/1538-7445.am2019-131
https://doi.org/10.1158/1538-7445.am2019-131